China is aiming to create an alternative medicine that works on the same underlying disease as the anti-depressant medication Zoloft.
The country’s state-run Xinhua news agency said in a commentary that the treatment could be available within two to three years.
It is not yet clear whether the drug will be licensed.
The announcement comes as a major pharmaceutical company said it would invest $5 billion in developing and testing a generic version of Zolft.
China is seeking to develop a drug to treat chronic fatigue, or fatigue-related diseases, that are common in China.
In August, China announced that it had started developing a new treatment that it said would treat people with the disease.
Zoloft, which was approved in China in 2007, was prescribed to help people cope with severe and debilitating symptoms of the disease, such as exhaustion and sleep disturbance.